PF-Atlas › Clinical Trials › NCT03299231
Oscillating Positive Expiratory Pressure Devices and Acute Exacerbation of Chronic Obstructive Pulmonary Disease
OPEP Aerobika · Not specified
Registry ID
NCT03299231
Phase
Not specified
Status
Unknown
Drug / intervention
OPEP Aerobika
Sponsor
Ain Shams University
Start
2018-01-22
Enrollment
160
Locations
1
About this trial
Sputum production increases in acute exacerbation of COPD, both in amount and consistency. It increases airways obstruction and hence delays improvement and prolongs hospital stay. oscillating positive expiratory pressure (OPEP) devices were extensively studied in cystic fibrosis and bronchiectasis. Only seldom studied in chronic bronchitis. This study aims to measure the effects of mucous clearing device in hospitalized patients with acute exacerbation of COPD.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT03299231 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.